![]()
Personalized briefing
Discovery of the day · Neurology
AGG repeat expansion and aggregation of BIN1 in multiple system atrophy
Dear Kelly M Leyden, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology
Discovery of the day
Whole-genome and long-read sequencing identified an AGG repeat expansion in the first intron of BIN1 as a novel genetic factor in multiple system atrophy (MSA), a fatal sporadic α-synucleinopathy. In a pathologically confirmed MSA cohort, repeat expansions exceeding 80 repeats were significantly enriched (13.4% vs. 0% in brain controls, P=0.003), with BIN1-positive glial cytoplasmic inclusions and increased insoluble BIN1 protein aggregates observed in affected brains. For your focus on blood-based proteomic biomarkers, this finding positions BIN1 aggregation as a candidate pathological driver and potential protein biomarker target that could be measured in biofluids and correlated with neuroimaging or clinical progression to improve diagnostic assays for neurodegenerative diseases.
Novelty
92%
Rigor
91%
Significance
90%
Validity
95%
Clarity
93%
Also in this briefing
Medicine · Neurology
Secondary
AHA1, an Hsp90 co-chaperone, was demonstrated to regulate Aβ production through dual mechanisms—modulating APP protein abundance and promoting γ-secretase assembly—consistent with its role in Alzheimer’s disease amyloidogenic processing. Familial AD mutations upregulate AHA1/Hsp90, elevating APP/APH1 and Aβ42, while AHA1 knockdown rescues this overproduction in mutant cell models, suggesting AHA1 as a therapeutic target. This mechanistic finding may guide the development of protein-based biomarkers for AD activity and support correlation with multimodal clinical and imaging data relevant to your neurodegenerative disease focus.
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.

